Low cytoplasmic expression of ADAMTS14 has been associated with poor overall survival of patients with oral squamous cell carcinoma, which may be used as a novel biomarker for oral squamous cell carcinoma diagnosis [37]. This evidence concerns the gene ADAMTS14 and oral cavity squamous cell carcinoma.